RxDoctor Payments Data

Christina Woods

Psychiatric/Mental Health · Corbin, KYNPI 1780293027

Payments from drug & device makers

$1,459in general payments, 2019–2025

Across 80 payments — averaging $18.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$618
  • AbbVie$254
  • Neurocrine Biosciences, Inc.$97
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$94
  • Ironshore Pharmaceuticals Inc.$69
  • Teva Pharmaceuticals USA, Inc.$48
  • plus $277 from 9 others

What the payments were for

  • Food & beverage$1,459100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,459 in reported general payments places this provider in the 65th percentile of 946 psychiatric/mental health providers in Kentucky.

See all psychiatric/mental health providers in Kentucky

Medicare billing

Part B allowed, 2024
$9,697
Medicare patients
31
Services billed
91

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Risperdal ConstaRisperidone Microspheres13$33,595
RexultiBrexpiprazole14$25,760
VraylarCariprazine Hcl17$23,209
SaphrisAsenapine Maleate12$14,176
Lurasidone Hcl16$5,064
Aripiprazole64$3,275
Oxcarbazepine25$2,556
Duloxetine Hcl52$2,324
Fluoxetine Hcl75$1,729
Buspirone Hcl103$1,349
Bupropion XlBupropion Hcl90$1,271
Quetiapine Fumarate110$1,174
Olanzapine25$959
Mirtazapine70$806
Vilazodone Hcl12$786

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar, Saphris$254$37,38529 claims
Johnson & JohnsonRisperdal Consta$44$33,59513 claims
Otsuka America Pharmaceutical, Inc.Rexulti$41$25,76014 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 946 psychiatric/mental health providers in Kentucky.

Other psychiatric/mental health in Corbin

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →